Patent ID: 7935728

Claim:
A cyclopalladated organometallic compound having palladium, a Sigma C—Pd bond, and a coordination bond Y→Pd, originating an organic cycle with a formula corresponding to the structure: or a pharmaceutical acceptable salt thereof wherein: X is selected from the group consisting of Cl, N 3 , NCO, NCS, SCN and H 3 C—COO − ; Y is a nitrogen atom in a moiety selected from the group consisting of N,N-dimethyl-1-phenethylamine (dmpa), pyridinyl-phenyl-ethine, and 1-phenyl-3-N,N-dimethylamine-propine; C is an atom of carbon with sp 2 or sp 3 hybridization covalently bonded to the atom of palladium; and the ring containing C, Y and Pd includes three to eight atoms; between C and Y there is a succession of atoms designated as a cyclopalladated ring; and L is a coordinated ligand selected from the group consisting of N, P, As, Sb, and Bi and both of the L are within a bis-diphenylphosphine-ferrocene compound as in Scheme 2: wherein R1, R2, R3, and R4 are individually selected from the group consisting of phenyl, hydrogen (H), alkyl, aryl, dienyl, alkoxy, siloxy, hydroxy (OH), amine (—NH 2 ), imide, halogen (F, Cl, Br, I), imine, and nitro (—NO 2 ); and R5, R6, R7, R8, R9, R10, R11, and R12 are individually selected from the group consisting of: hydrogen (H), alkyl, aryl, dienyl, alkoxy, siloxy, hydroxy (OH), amine (—NH2), imide, halogen (F, Cl, Br, I), imine, and nitro (—NO2).